

Compact for Safe Cosmetics
|
Animal Testing Policy |


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Miscellaneous, Multiple, additive exposure sources, Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Ingredients from packaging: WATER, WATER, CYCLOHEXASILOXANE, CYCLOPENTASILOXANE, CETEARYL ISONONANOATE, DECYL OLEATE, ISONONYL ISONONANOATE, UREA, GLYCERIN, CETEARYL ALCOHOL, DIETHYLHEXYLCYCLOHEXANE, BUTYLENE GLYCOL, CETEARETH-20, CETYL PALMITATE, SQUALANE, ALGAE EXTRACT, FRAGRANCE, CETEARETH-12, GLYCERYL STEARATE, PROPYLENE GLYCOL, LARREA DIVARICATA EXTRACT, PHENOXYETHANOL, SODIUM DEHYDROACETATE, METHYLPARABEN, LINOLEIC ACID, LINOLENIC ACID, TRISODIUM EDTA, LECITHIN, PROPYLPARABEN, BUTYLPARABEN, ETHYLPARABEN
| score | data gap | concerns | |
| METHYLPARABEN | 10 | 63% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Biochemical or cellular level changes |
| FRAGRANCE | 8 | 100% | Neurotoxicity, Allergies/immunotoxicity, Miscellaneous |
| CETEARETH-12 | 5 | 71% | Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE) |
| CETEARETH-20 | 5 | 71% | Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE) |
| BUTYLPARABEN | 6 | 79% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
| LECITHIN | 6 | 70% | Allergies/immunotoxicity, Multiple, additive exposure sources, Enhanced skin absorption, Contamination concerns (NITROSAMINES) |
| ETHYLPARABEN | 5 | 80% | Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| PROPYLPARABEN | 5 | 71% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| PHENOXYETHANOL | 4 | 67% | Violations, restrictions & warnings, Allergies/immunotoxicity, Irritation (skin, eyes, or lungs), Occupational hazards |
| UREA | 4 | 67% | Violations, restrictions & warnings, Irritation (skin, eyes, or lungs), Enhanced skin absorption |
| PROPYLENE GLYCOL | 4 | 60% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Enhanced skin absorption |
| CYCLOPENTASILOXANE | 2 | 79% | Persistence and bioaccumulation |
| CYCLOHEXASILOXANE | 1 | 82% | Persistence and bioaccumulation |
| SODIUM DEHYDROACETATE | 2 | 78% | Occupational hazards |
| GLYCERIN | 2 | 74% | Organ system toxicity (non-reproductive), Occupational hazards |
| LINOLENIC ACID | 1 | 94% | Organ system toxicity (non-reproductive) |
| CETEARYL ALCOHOL | 0 | 93% | none identified |
| LINOLEIC ACID | 1 | 93% | Irritation (skin, eyes, or lungs) |
| SQUALANE | 1 | 93% | Irritation (skin, eyes, or lungs) |
| CETYL PALMITATE | 1 | 92% | Irritation (skin, eyes, or lungs) |
| GLYCERYL MONOSTEARATE GLYCERYL STEARATE | 1 | 88% | none identified |
| TRISODIUM EDTA | 1 | 86% | Enhanced skin absorption |
| BUTYLENE GLYCOL | 1 | 79% | Irritation (skin, eyes, or lungs) |
| CETEARYL ISONONANOATE | 0 | 100% | none identified |
| DIOCTYLCYCLOHEXANE DIETHYLHEXYLCYCLOHEXANE | 0 | 100% | none identified |
| ISONONYL ISONONANOATE | 0 | 100% | none identified |
| LARREA DIVARICATA (CREOSOTE BUSH) EXTRACT LARREA DIVARICATA EXTRACT | 0 | 100% | none identified |
| ALGAE EXTRACT | 0 | 94% | none identified |
| DECYL OLEATE | 0 | 93% | none identified |
| WATER | 0 | 0% | innocuous |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more in vitro tests non-mammalian cells show positive mutation results | PHENOXYETHANOL | |
| One or more animal studies show tumor formation at moderate doses | CYCLOPENTASILOXANE | |
| One or more in vitro tests on mammalian cells show positive mutation results | UREA, SODIUM DEHYDROACETATE, PROPYLPARABEN, PROPYLENE GLYCOL, METHYLPARABEN, GLYCERIN, ETHYLPARABEN, BUTYLPARABEN |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show reproductive effects at high doses | UREA, SODIUM DEHYDROACETATE, ETHYLPARABEN, BUTYLENE GLYCOL | |
| One or more animal studies show reproductive effects at moderate doses | PROPYLENE GLYCOL, GLYCERIN | |
| One or more animal studies show any effects at low doses | PROPYLPARABEN | |
| One or more animal studies show any effects at very low doses | BUTYLPARABEN |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | PROPYLENE GLYCOL, CETEARETH-20, LECITHIN, CETEARETH-12 | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | UREA, PHENOXYETHANOL | |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | METHYLPARABEN |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | SODIUM DEHYDROACETATE, PROPYLENE GLYCOL, GLYCERIN, BUTYLENE GLYCOL | |
| One or more animal studies show brain and nervous system effects at moderate doses | UREA, PHENOXYETHANOL, METHYLPARABEN, LECITHIN, CETEARETH-12, CETEARETH-20, | |
| One or more animal studies show any effects at moderate doses | CYCLOPENTASILOXANE | |
| Moderate evidence of human neurotoxicity | FRAGRANCE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | CYCLOHEXASILOXANE, GLYCERIN | |
| One or more animal studies show endocrine disruption at moderate doses | CYCLOPENTASILOXANE | |
| One or more animal studies show endocrine system disruption at high doses | BUTYLENE GLYCOL | |
| Human any disruptor - strong evidence | PROPYLPARABEN, METHYLPARABEN, ETHYLPARABEN, BUTYLPARABEN |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Human skin toxicant - strong evidence | BUTYLPARABEN | |
| Limited evidence of skin and immune system toxicity | PHENOXYETHANOL | |
| Limited evidence of skin and immune system toxicity | PROPYLENE GLYCOL | |
| Human skin toxicant - strong evidence | PROPYLPARABEN, METHYLPARABEN, ETHYLPARABEN | |
| Known human immune system toxicant | FRAGRANCE | |
| Human immune and respiratory toxicant - strong evidence | AND products that may be aerosolized (airborne) | LECITHIN |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Persistent, bioaccumulative in wildlife | CYCLOPENTASILOXANE | |
| Not suspected to be persistent | LINOLENIC ACID | |
| Persistent, bioaccumulative in wildlife | CYCLOHEXASILOXANE |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Classified as expected to be toxic or harmful | LINOLENIC ACID | |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | CYCLOPENTASILOXANE, CYCLOHEXASILOXANE, BUTYLENE GLYCOL | |
| One or more animal studies show respiratory effects at moderate doses (low dose studies may be unavailable for this ingredient) | products that may be aerosolized (airborne) | UREA, CETEARETH-20, CETEARETH-12 |
| One or more animal studies show kidney or renal system effects at moderate doses (low dose studies may be unavailable for this ingredient) | TRISODIUM EDTA, PHENOXYETHANOL, SODIUM DEHYDROACETATE, LINOLEIC ACID | |
| Limited evidence of sense organ toxicity | PROPYLPARABEN | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | GLYCERYL MONOSTEARATE | |
| Limited evidence of sense organ toxicity | ETHYLPARABEN, BUTYLPARABEN | |
| One or more animal studies show kidney or renal system effects at very low doses | GLYCERIN | |
| Known human any toxicant | METHYLPARABEN | |
| Limited evidence of respiratory toxicity | products that may be aerosolized (airborne) | PROPYLENE GLYCOL |
*This table includes all possible miscellaneous concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Ingredient not fully labeled - identity unknown | FRAGRANCE |
*This table includes all possible multiple, additive exposure sources concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Designated as safe for general or specific, limited use in food | UREA, SODIUM DEHYDROACETATE, PROPYLPARABEN, PROPYLENE GLYCOL, METHYLPARABEN, LINOLEIC ACID, LECITHIN, GLYCERYL MONOSTEARATE, GLYCERIN, BUTYLPARABEN, BUTYLENE GLYCOL | |
| Used in food or as an additive with limited or no toxicity information available | LECITHIN |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Wildlife and environmental toxicity | PROPYLPARABEN | |
| Suspected to be an environmental toxin | LINOLENIC ACID |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at moderate doses | GLYCERIN, CYCLOPENTASILOXANE, BUTYLPARABEN | |
| One or more animal studies show skin irritation at low doses | UREA, SQUALANE, METHYLPARABEN, LINOLEIC ACID | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | CETYL PALMITATE |
| One or more animal studies show skin irritation at low doses | CETEARETH-12, CETEARETH-20 | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | BUTYLENE GLYCOL |
| Classified as skin irritant | PROPYLENE GLYCOL, PHENOXYETHANOL |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Safety assessment was based on related chemical | PROPYLENE GLYCOL | |
| Safety unknown for products that may be inhaled | products that may be aerosolized (airborne) | LECITHIN |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | UREA, SODIUM DEHYDROACETATE, TRISODIUM EDTA, PROPYLPARABEN, PHENOXYETHANOL, METHYLPARABEN, CETYL PALMITATE, GLYCERYL MONOSTEARATE, DECYL OLEATE, ETHYLPARABEN, BUTYLPARABEN, CETEARYL ALCOHOL, BUTYLENE GLYCOL | |
| Not assessed for safety in cosmetics by industry panel | SQUALANE, LINOLENIC ACID, LINOLEIC ACID, LARREA DIVARICATA (CREOSOTE BUSH) EXTRACT, ISONONYL ISONONANOATE, GLYCERIN, FRAGRANCE, DIOCTYLCYCLOHEXANE, CYCLOPENTASILOXANE, CYCLOHEXASILOXANE, CETEARYL ISONONANOATE, ALGAE EXTRACT |
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to moderate doses | GLYCERIN | |
| Allowed workplace exposures restricted to low doses | SODIUM DEHYDROACETATE, PHENOXYETHANOL |
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Interferes with gene expresion | BUTYLPARABEN, METHYLPARABEN | |
| One or more animal studies show blood sugar changes at high doses where the human health implications are not yet well understood | PROPYLENE GLYCOL, GLYCERIN, CYCLOPENTASILOXANE |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.